These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

695 related items for PubMed ID: 12112314

  • 1. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
    Manderson EN, Presneau N, Provencher D, Mes-Masson AM, Tonin PN.
    Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314
    [Abstract] [Full Text] [Related]

  • 2. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.
    Fullwood P, Marchini S, Rader JS, Martinez A, Macartney D, Broggini M, Morelli C, Barbanti-Brodano G, Maher ER, Latif F.
    Cancer Res; 1999 Sep 15; 59(18):4662-7. PubMed ID: 10493522
    [Abstract] [Full Text] [Related]

  • 3. Mapping of chromosome 3p deletions in human epithelial ovarian tumors.
    Lounis H, Mes-Masson AM, Dion F, Bradley WE, Seymour RJ, Provencher D, Tonin PN.
    Oncogene; 1998 Nov 05; 17(18):2359-65. PubMed ID: 9811467
    [Abstract] [Full Text] [Related]

  • 4. Loss of heterozygosity at chromosome segment Xq25-26.1 in advanced human ovarian carcinomas.
    Choi C, Cho S, Horikawa I, Berchuck A, Wang N, Cedrone E, Jhung SW, Lee JB, Kerr J, Chenevix-Trench G, Kim S, Barrett JC, Koi M.
    Genes Chromosomes Cancer; 1997 Nov 05; 20(3):234-42. PubMed ID: 9365830
    [Abstract] [Full Text] [Related]

  • 5. Loss of heterozygosity on chromosomes 3, 9, 13, and 17, including the retinoblastoma locus, in uveal melanoma.
    Scholes AG, Liloglou T, Maloney P, Hagan S, Nunn J, Hiscott P, Damato BE, Grierson I, Field JK.
    Invest Ophthalmol Vis Sci; 2001 Oct 05; 42(11):2472-7. PubMed ID: 11581185
    [Abstract] [Full Text] [Related]

  • 6. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
    Wistuba II, Behrens C, Virmani AK, Mele G, Milchgrub S, Girard L, Fondon JW, Garner HR, McKay B, Latif F, Lerman MI, Lam S, Gazdar AF, Minna JD.
    Cancer Res; 2000 Apr 01; 60(7):1949-60. PubMed ID: 10766185
    [Abstract] [Full Text] [Related]

  • 7. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
    Thrash-Bingham CA, Salazar H, Freed JJ, Greenberg RE, Tartof KD.
    Cancer Res; 1995 Dec 15; 55(24):6189-95. PubMed ID: 8521412
    [Abstract] [Full Text] [Related]

  • 8. Loss of heterozygosity, microsatellite instability and TP53 gene status in ovarian carcinomas.
    Plisiecka-Hałasa J, Dansonka-Mieszkowska A, Kraszewska E, Dańska-Bidzińska A, Kupryjańczyk J.
    Anticancer Res; 2008 Dec 15; 28(2A):989-96. PubMed ID: 18507046
    [Abstract] [Full Text] [Related]

  • 9. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
    Cornelis RS, van Vliet M, Vos CB, Cleton-Jansen AM, van de Vijver MJ, Peterse JL, Khan PM, Børresen AL, Cornelisse CJ, Devilee P.
    Cancer Res; 1994 Aug 01; 54(15):4200-6. PubMed ID: 8033152
    [Abstract] [Full Text] [Related]

  • 10. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
    Lininger RA, Zhuang Z, Man Y, Park WS, Emmert-Buck M, Tavassoli FA.
    Mod Pathol; 1999 Dec 01; 12(12):1083-9. PubMed ID: 10619258
    [Abstract] [Full Text] [Related]

  • 11. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
    Singh RB, Amare Kadam PS.
    Urol Oncol; 2013 Oct 01; 31(7):1333-42. PubMed ID: 21962529
    [Abstract] [Full Text] [Related]

  • 12. [Loss of heterozygosity at chromosome 3p14, 25 in serum DNA from ovarian cancer patients].
    Zhang H, Li Z, Chen M, Zhang G, Xu K.
    Zhonghua Fu Chan Ke Za Zhi; 2002 May 01; 37(5):298-300. PubMed ID: 12133406
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas.
    Dodson MK, Hartmann LC, Cliby WA, DeLacey KA, Keeney GL, Ritland SR, Su JQ, Podratz KC, Jenkins RB.
    Cancer Res; 1993 Oct 01; 53(19):4456-60. PubMed ID: 8402612
    [Abstract] [Full Text] [Related]

  • 16. Frequent allelic loss at chromosome arm 3p is distinct from genetic alterations of the Von-Hippel Lindau tumor suppressor gene in head and neck cancer.
    Waber PG, Lee NK, Nisen PD.
    Oncogene; 1996 Jan 18; 12(2):365-9. PubMed ID: 8570213
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A region close to Tp53 shows LOH in familial breast cancer.
    Luo L, Chen J, Du Q, Dumanski J, Blennow E, Kockum I, Luthman H, Lindblom A.
    Int J Mol Med; 2002 Apr 18; 9(4):405-9. PubMed ID: 11891537
    [Abstract] [Full Text] [Related]

  • 20. Allelic loss at BRCA1, BRCA2, and adjacent loci in relation to TP53 abnormality in breast cancer.
    Tseng SL, Yu IC, Yue CT, Chang SF, Chang TM, Wu CW, Shen CY.
    Genes Chromosomes Cancer; 1997 Dec 18; 20(4):377-82. PubMed ID: 9408754
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.